BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23176660)

  • 21. Serum and colonic mucosal immune markers in irritable bowel syndrome.
    Chang L; Adeyemo M; Karagiannides I; Videlock EJ; Bowe C; Shih W; Presson AP; Yuan PQ; Cortina G; Gong H; Singh S; Licudine A; Mayer M; Tache Y; Pothoulakis C; Mayer EA
    Am J Gastroenterol; 2012 Feb; 107(2):262-72. PubMed ID: 22158028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism.
    Barbaro MR; Di Sabatino A; Cremon C; Giuffrida P; Fiorentino M; Altimari A; Bellacosa L; Stanghellini V; Barbara G
    Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G439-47. PubMed ID: 26744473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colonic mucosal N-methyl-D-aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome.
    Qi QQ; Chen FX; Zhao DY; Li LX; Wang P; Li YQ; Zuo XL
    J Dig Dis; 2016 Jul; 17(7):448-57. PubMed ID: 27356126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postinfectious irritable bowel syndrome.
    Barbara G; Cremon C; Pallotti F; De Giorgio R; Stanghellini V; Corinaldesi R
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S95-7. PubMed ID: 19300138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
    Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
    Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered interaction between enteric glial cells and mast cells in the colon of women with irritable bowel syndrome.
    Meira de-Faria F; Casado-Bedmar M; Mårten Lindqvist C; Jones MP; Walter SA; Keita ÅV
    Neurogastroenterol Motil; 2021 Nov; 33(11):e14130. PubMed ID: 33797165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells.
    Vivinus-Nébot M; Dainese R; Anty R; Saint-Paul MC; Nano JL; Gonthier N; Marjoux S; Frin-Mathy G; Bernard G; Hébuterne X; Tran A; Theodorou V; Piche T
    Am J Gastroenterol; 2012 Jan; 107(1):75-81. PubMed ID: 21931380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin transporter gene promoter region polymorphisms and serotonin transporter expression in the colonic mucosa of irritable bowel syndrome patients.
    Wang YM; Chang Y; Chang YY; Cheng J; Li J; Wang T; Zhang QY; Liang DC; Sun B; Wang BM
    Neurogastroenterol Motil; 2012 Jun; 24(6):560-5, e254-5. PubMed ID: 22435794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colonic soluble mediators from the maternal separation model of irritable bowel syndrome activate submucosal neurons via an interleukin-6-dependent mechanism.
    O'Malley D; Liston M; Hyland NP; Dinan TG; Cryan JF
    Am J Physiol Gastrointest Liver Physiol; 2011 Feb; 300(2):G241-52. PubMed ID: 21109592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alterations of intestinal epithelial barrier and flora in the irritable bowel syndrome].
    Piche T
    Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S40-7. PubMed ID: 19303538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype.
    Bertiaux-Vandaële N; Youmba SB; Belmonte L; Lecleire S; Antonietti M; Gourcerol G; Leroi AM; Déchelotte P; Ménard JF; Ducrotté P; Coëffier M
    Am J Gastroenterol; 2011 Dec; 106(12):2165-73. PubMed ID: 22008894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea.
    Vazquez-Roque MI; Camilleri M; Smyrk T; Murray JA; O'Neill J; Carlson P; Lamsam J; Eckert D; Janzow D; Burton D; Ryks M; Rhoten D; Zinsmeister AR
    Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(11):G1262-9. PubMed ID: 23042942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome.
    Camilleri M; Lasch K; Zhou W
    Am J Physiol Gastrointest Liver Physiol; 2012 Oct; 303(7):G775-85. PubMed ID: 22837345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of serotonin in the pathophysiology of the irritable bowel syndrome].
    Moskwa A; Boznańska P
    Wiad Lek; 2007; 60(7-8):371-6. PubMed ID: 18175558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Increase of intraepithelial lymphocytes in patients with irritable bowel syndrome].
    Arévalo F; Aragon V; Montes P; Guzmán E; Monge E
    Rev Gastroenterol Peru; 2011; 31(4):315-8. PubMed ID: 22476118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+CD25+ regulatory T cells in irritable bowel syndrome patients.
    Holmén N; Isaksson S; Simrén M; Sjövall H; Ohman L
    Neurogastroenterol Motil; 2007 Feb; 19(2):119-25. PubMed ID: 17244166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammation in irritable bowel syndrome: Myth or new treatment target?
    Sinagra E; Pompei G; Tomasello G; Cappello F; Morreale GC; Amvrosiadis G; Rossi F; Lo Monte AI; Rizzo AG; Raimondo D
    World J Gastroenterol; 2016 Feb; 22(7):2242-55. PubMed ID: 26900287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes of tight junction claudin-1,-3,-4 protein expression in the intestinal mucosa in patients with irritable bowel syndrome].
    Kong WM; Gong J; Dong L; Xu JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1345-7. PubMed ID: 17884774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.
    Coëffier M; Gloro R; Boukhettala N; Aziz M; Lecleire S; Vandaele N; Antonietti M; Savoye G; Bôle-Feysot C; Déchelotte P; Reimund JM; Ducrotté P
    Am J Gastroenterol; 2010 May; 105(5):1181-8. PubMed ID: 19997094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?
    Hughes PA; Zola H; Penttila IA; Blackshaw LA; Andrews JM; Krumbiegel D
    Am J Gastroenterol; 2013 Jul; 108(7):1066-74. PubMed ID: 23649183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.